No black box warning on record for Heparin Sodium In Dextrose

As of the latest FDA labeling reviewed, Heparin Sodium In Dextrose (HEPARIN SODIUM AND DEXTROSE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Heparin Sodium In Dextrose medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Fatal Medication Errors: Confirm choice of correct strength prior to administration. ( 5.1 ) Hemorrhage: Fatal cases have occurred. Monitor for signs of bleeding and manage promptly. ( 5.2 ) HIT or HITT: Monitor for signs and symptoms and discontinue if indicative of HIT or HITT. ( 5.3 ) Thrombocytopenia: Monitor platelet count during therapy; discontinue heparin in HIT

No black box warning on record for Heparin Sodium In Dextrose

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Fatal Medication Errors: Confirm choice of correct strength prior to administration. ( 5.1 ) Hemorrhage: Fatal cases have occurred. Monitor for signs of bleeding and manage promptly. ( 5.2 ) HIT or HITT: Monitor for signs and symptoms and discontinue if indicative of HIT or HITT. ( 5.3 ) Thrombocytopenia: Monitor platelet count during therapy; discontinue heparin in HIT

Heparin Sodium In Dextrose Black Box Warning

No black box warning on record for Heparin Sodium In Dextrose

Other warnings & precautions

Heparin Sodium In Dextrose Black Box Warning

No black box warning on record for Heparin Sodium In Dextrose

Other warnings & precautions